Anticancer and Antioxidant Activities in Ganoderma lucidum Wild Mushrooms in Poland, as Well as Their Phenolic and Triterpenoid Compounds

Int J Mol Sci. 2022 Aug 19;23(16):9359. doi: 10.3390/ijms23169359.

Abstract

The goal of this study was to the assess anti-cancer and antioxidant properties of the Ganoderma lucidum fruiting body, and to identify bioactive compounds found in their extracts. Significant antiproliferative activity was observed against MCF-7, MCF-7/DX, LOVO, LOVO/DX, MDA-MB 231, SW 620, and NHDF cell lines. With IC50 values of 25.38 µg/mL and 47.90 µg/mL, respectively, the extract was most effective against MDA-MB 231 and SW 620 cell lines. The bioactive compounds were identified using an ACQUITY UPLC-PDA-MS system. The extracts contained 13 triterpenoids and 28 polyphenols from the flavonols, phenolic acids, flavones, flavan-3-ols, and stilbenes families. Ganoderic acid derivative was found to be the most abundant triterpenoid (162.4 mg/g DW), followed by ganoderic acid B (145.6 mg/g DW). Resveratrol was the most abundant phenolic in the extract (5155.7 mg/100 g DM). The findings could explain why G. lucidum extracts are used in folk medicine.

Keywords: LC-MS; antioxidants; bioactive compounds; lingzhi; mushrooms; reishi.

MeSH terms

  • Agaricales*
  • Antineoplastic Agents* / pharmacology
  • Antioxidants / pharmacology
  • Ganoderma*
  • Humans
  • Phenols / pharmacology
  • Phytochemicals
  • Poland
  • Polyphenols
  • Reishi*
  • Triterpenes* / analysis
  • Triterpenes* / pharmacology

Substances

  • Antineoplastic Agents
  • Antioxidants
  • Phenols
  • Phytochemicals
  • Polyphenols
  • Triterpenes

Grants and funding

This research received no external funding.